Navigation Links
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Date:10/31/2008

ure that is synthesized to combine an alkylating group and a purine-like benzimidazole component. Though the exact mechanism of action of TREANDA remains unknown, TREANDA may act in two distinct ways to kill cancer cells. Preclinical studies suggest that TREANDA may lead to cell death by a process known as apoptosis (programmed cell death) as well as by an alternate cell death pathway which disrupts normal cell division known as mitotic catastrophe (a non-apoptotic pathway).

Cephalon holds exclusive rights to market and develop TREANDA in the United States. TREANDA is licensed from Astellas Deutschland GmbH. Bendamustine HCl, the active ingredient in TREANDA, is marketed in Germany by Astellas' licensee, Mundipharma International Corporation Limited. In Germany, bendamustine is indicated as a single-agent or in combination with other anti-cancer agents for indolent NHL, multiple myeloma, and CLL. SymBio Pharmaceuticals Ltd holds exclusive rights to develop and market bendamustine HCl in Japan and select Asia Pacific Rim countries.

About Cephalon Oncology

Cephalon, a leading biopharmaceutical company, is building a diversified portfolio of oncology products that represents a comprehensive approach to extend and enhance the lives of patients with cancer. Cephalon Oncology is a strategic business unit focused on the development and commercialization of oncology products and resources for patients and healthcare providers. The Cephalon Oncology portfolio includes a number of promising investigational and marketed compounds. In addition to TREANDA, the Cephalon Oncology therapeutic portfolio in the United States includes TRISENOX(R) (arsenic trioxide) injection, a product approved in the United States for the treatment of patients with relapsed or refractory acute promyelocytic leukemia, and CEP- 701, an oral small molecule inhibitor of tyrosine kinases including FLT-3, TRK and JAK-2, in phase 3 development for acute myeloid leukemia.

In Europ
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
2. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
3. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
4. Cephalon Conference Call Invitation
5. Cephalon Reports Strong First Quarter Earnings
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
8. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
9. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
10. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... CA (PRWEB) April 02, 2015 Veale ... and now two digital billboards to its name, announces ... billboard in the Dixon/Sacramento area. Similar to the ... freeway in Rohnert Park, California, the addition means, in ... the much sought after tourist population traveling through ...
(Date:4/2/2015)... 2015 New York Dynamic Neuromuscular Rehabilitation ... time in New York City, a groundbreaking, conservative method ... stroke (or other types of neurological diseases that damage ... A stroke is considered a cerebrovascular accident (CVA) that ... tissue resulting in damage to the nerve cells. Damage ...
(Date:4/1/2015)... Alcohol Awareness Month , The National Council ... sponsoring Alcohol Awareness Month every April since 1987. ... understating of alcohol-related issues. During the month of ... and alcoholism. , For the Health of It: Early ... for Alcohol Awareness Month. During April, focus is ...
(Date:4/1/2015)... April 01, 2015 NTOCC today launches ... of care tools that seek to improve care transitions ... program, NTOCC hopes to bring light to tools or ... of care across the healthcare industry through the promotion ... advance collaborative patient-care. Following that vision, the Knowledge & ...
(Date:4/1/2015)... 2015 New Jersey Governor First ... First Spouses from across the country in sponsoring ... 2015, World Down Syndrome Day(WDSD), to increase awareness ... area of Down syndrome cognition research. , In ... Alaska, American Samoa, Arizona, California, Colorado, Delaware, Florida, ...
Breaking Medicine News(10 mins):Health News:Veale Outdoor Advertising State of the Art Digital Billboards Reach 12 Million in SF Bay Area 2Health News:Virtual Environment Treatment Available for the First Time in NYC for Patients with Stroke 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 3Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2
... University of North Carolina in Chapel Hill that was published ... suggests that two genes - C282Y and H63D, which are ... to an increased risk of developing colon cancer. For the ... out// of which, more than 400 already had colon cancer, ...
... at Trinity College, Dublin, Ireland, have found from a ... arterial stiffness after smoking even one cigarette in both ... effects of smoking on large artery properties in 185 ... years. 116 non-smokers// were compared with 41 chronic smokers ...
... Patients with damaged discs have traditionally been treated by removing ... to fuse two bones together. Now, an artificial disc which ... phase of trials. The phase one study that was recently ... first phase of trials patients// were randomized, with one having ...
... banned in 1962, is being reassessed to find out if ... forms of cancer and leprosy. The drug which is unlicensed ... a cure for morning// sickness. However, it was banned after ... ,The European Agency for the Evaluation of Medicinal Products (EMEA) ...
... that were known until now were chickenpox, ear infections, ... found that stroke is also among one of the ... A National Hospital's database analysis by Dr. Donna Ferriero, ... that four in 1000 newborns had a stroke. ...
... survey across England showed that many do not eat ... other serious diseases. The survey included nearly// 15,600 adults ... revealed by the study. ,The survey indicated that ... household income. Almost 40% of women in the highest ...
Cached Medicine News:Health News:Artificial discs available as replacements for damaged discs 2Health News:Stroke also in list of common childhood ailments 2
(Date:4/1/2015)... The Netherlands , April 1, 2015 /PRNewswire/ ... its ISO 13485 certificate for their 100% medical North ... medical device manufacturers throughout North America ... President of HealthLink Europe and HealthLink International: "We now ... in Europe and one in ...
(Date:4/1/2015)... LAVAL, Quebec , April 1, 2015 ... Salix "), a wholly owned subsidiary of Valeant Pharmaceuticals ... that it today provided a Notice of Fundamental Changes, ... Notice, Notice of Execution of Supplemental Indenture and Offer ... its 1.5% Convertible Senior Notes due 2019 (the " ...
(Date:4/1/2015)... April 1, 2015  New York College of Health ... Intellectual Properties portfolio with U.S. Patent #8,996,098 donated by ... patent represents a surgical instrument that allows surgeons to ... it were in the traditional format of a slide ... medical databases during surgery, thus providing the surgeon real ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3
... June 22 Hanger Orthopedic Group, Inc. (NYSE: HGR ... acquisition of Dynamic Orthotics and Prosthetics of Texas , Nebraska Orthotic ...  The companies operate 10 offices with annual revenues of $14.0 million ... "These companies ...
... 22 Xoft, makers of Electronic Brachytherapy systems ... integration of its Axxent® Electronic Brachytherapy System at the ... fully comprehensive breast center exclusively dedicated to the prevention, ... Lotus Breast Center is the first comprehensive breast center ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 3
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... present with fever, sore throat, ... symptoms common with a viral ... able to distinguish these from ... is the one-step antibody test ...
... hCG urine/serum combo test that you can ... and faster results at the point-of-care ... 20 hCG is a rapid test for ... immunoassay technology to selectively detect elevated levels ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Medicine Products: